Brookfield Corp’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-881,201
Closed -$9.81M 787
2022
Q4
$9.81M Sell
881,201
-244,049
-22% -$2.55M 0.04% 155
2022
Q3
$9.59M Buy
+1,125,250
New +$11.1M 0.04% 169
2022
Q2
Sell
-599,854
Closed -$6.53M 757
2022
Q1
$6.53M Buy
+599,854
New +$7.9M 0.02% 212
2021
Q1
Sell
-219,944
Closed -$4.12M 580
2020
Q4
$4.12M Buy
+219,944
New +$3.59M 0.02% 188

Other funds holding VTRS

Brookfield Corp's VTRS Position: Q1 2023 in Review

Brookfield Corp sold out of Viatris (VTRS) in Q1 2023, closing a stake of 881,201 shares — an estimated $9.81M sold.

Brookfield Corp first reported a position in VTRS in Q4 2020 and held it in 4 quarters. The position peaked at $9.81M in Q4 2022. 990 funds tracked by Wall St. Rank hold VTRS as of Q1 2023.

  • Brookfield Corp reported no remaining Viatris position as of Q1 2023 after selling out during the quarter.
  • Brookfield Corp sold 881,201 Viatris shares in Q1 2023, an estimated $9.81M.
  • Brookfield Corp first reported a position in Viatris in Q4 2020 and held it in 4 quarters.
  • Brookfield Corp's Viatris position peaked at $9.81M in Q4 2022.
  • 990 funds tracked by Wall St. Rank held Viatris as of Q1 2023.

Based on Brookfield Corp's 13F filing for Q1 2023, filed 15 May 2023.